SCHEMBL21057413

SCHEMBL21057413

C[C@@H]1C[C@H](C(=O)O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1OC(=S)n1ccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21057412 1.00 — —
SCHEMBL21138385 0.84 NAMPT (0.36) —
SCHEMBL12397956 0.79 — —
SCHEMBL3185280 0.77 — —
SCHEMBL12397951 0.77 — —
SCHEMBL13531898 0.74 APP (0.31) —
SCHEMBL12397933 0.73 RECQL (0.31) —
SCHEMBL21057359 0.70 BTK (0.33) —
SCHEMBL21057361 0.70 BTK (0.33) —
SCHEMBL21082031 0.70 BTK (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190185479-A1 BICYCLIC NITROGENATED HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2019-06-20 — — US disclosed
Send feedback